DDrare
Disease
Drug
Target Gene/Pathway
お問合せ先
EN
Recombinant-methionyl human glial cell line-derived neurotrophic factor
( DrugBank: - / KEGG DRUG: - )
1 disease
告示番号
疾患名
(ページ内リンク)
臨床試験数
6
パーキンソン病
1
6. パーキンソン病
臨床試験数
:
2,307
/
薬物数
:
2,007
- (
DrugBank
:
349
) /
標的遺伝子数
:
188
-
標的パスウェイ数
:
199
10
50
100
ALL
trials per page:
Showing 1 to 1 of 1 trials
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT00006488
(
ClinicalTrials.gov
)
October 2000
20001000
8/11/2000
20001108
Continuously Infused Intracerebral (IC)
Recombinant-Methionyl
Human
Glial
Cell
Line-Derived
Neurotrophic
Factor
(r-metHuGDNF) for the Treatment of Idiopathic Parkinson's Disease
Continuously Infused Intracerebral (IC)
Recombinant-Methionyl
Human
Glial
Cell
Line-Derived
Neurotro
...
Parkinson Disease
Drug:
recombinant-methionyl
human
glial
cell
line-derived
neurotrophic
factor
National Center for Research Resources (NCRR)
NULL
Completed
18 Years
75 Years
Both
Phase 1
United States